Atlas Invest | $25,000,000 | (Jan 22, 2026)
AiStrike | $7,000,000 | (Jan 22, 2026)
Zarminali Pediatrics | $110,000,000 | (Jan 22, 2026)
Certified by Founder
Lodge
VentureMed Inc.
start up
United States
- Plymouth, Minnesota
- 30/10/2025
- Series C
- $28,000,000
VENTUREMED IS AN INNOVATOR in vessel preparation and drug delivery for the interventional treatment in AV access and PAD. The company’s Kinetic Micro-Incision Creation (K-MIC) make vessel preparation simpler, and more cost-effective with better outcomes. VentureMed offers interventionalists and their patients around the world state-of-the-art devices for treating lesions in AV and PAD. Founded by a vascular surgeon, VentureMed is committed to improving patient and economic outcomes.
- Industry Medical Device
- Website https://www.venturemedgroup.com/
- LinkedIn https://www.linkedin.com/company/venturemed-group/
![OSYTE [O-Sight]](/uploads/elmpLMcVgikenkl1732071438.png)
AnswersNow | $40,000,000 | (Jan 22, 2026)
Claim Health | $4,400,000 | (Jan 22, 2026)
Upscale AI(US) | $200,000,000 | (Jan 22, 2026)
Nasdaq Private Market | $37,600,000 | (Jan 22, 2026)
PraxisPro | $6,000,000 | (Jan 22, 2026)
furl | $10,000,000 | (Jan 22, 2026)
Statusphere | $18,000,000 | (Jan 21, 2026)
Think Bioscience | $55,000,000 | (Jan 21, 2026)
Formulary Financial | $4,600,000 | (Jan 21, 2026)